Affordable Access

Patents, genomics, research, and diagnostics.

Authors
Type
Published Article
Journal
Academic medicine : journal of the Association of American Medical Colleges
Publication Date
Volume
77
Issue
12 Pt 2
Pages
1339–1347
Identifiers
PMID: 12480644
Source
Medline
Keywords
License
Unknown

Abstract

Two kinds of currently available genomic patents may significantly interfere with medical research: (1) patents such as those on specific single nucleotide polymorphisms (SNPs), which may include claims that control the inference of phenotypic characteristics from specific genotypes, and (2) patents on computer-based genomic information, databases, or manipulation procedures. These will create more serious encumbrances than will patents on expressed sequence tags (ESTs). Two approaches should be considered vis-à-vis these genomic patents: (1) Reconsideration and redefinition of the recent extensions of patentable subject matter into more and more intangible areas. This could be pursued by legislation or by test litigation to seek Supreme Court reversal of certain of the decisions of the Court of Appeals for the Federal Circuit (CAFC). (2) A narrow legislative exemption protecting the ability to use SNPs and phenotypic-genotypic relationships in medical research, including contexts in which medical research and clinical practice are substantially intertwined.

Statistics

Seen <100 times